Koers Merchavia Holdings and Investments Ltd TEL AVIV STOCK EXCHANGE
Aandelen
MRHL
IL0002570146
Biotechnologie & Medisch Onderzoek
Omzet 2021 | 10,61 mln. 2,9 mln. 2,69 mln. | Omzet 2022 | 4,16 mln. 1,14 mln. 1,05 mln. | Marktkapitalisatie | 27,02 mln. 7,38 mln. 6,84 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 5 mln. 1,36 mln. 1,27 mln. | Nettowinst (verlies) 2022 | -3 mln. -819K -760K | EV/omzet 2021 | 4,7 x |
Nettoliquiditeiten 2021 | 7,43 mln. 2,03 mln. 1,88 mln. | Nettoliquiditeiten 2022 | 4,25 mln. 1,16 mln. 1,08 mln. | EV/omzet 2022 | 5,47 x |
K/w-verhouding 2021 |
9,97
x | K/w-verhouding 2022 |
-7,9
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 35,41% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eli Arad
CEO | Chief Executive Officer | 51 | 09-12-10 |
Ilan Goldstein
PSD | President | 62 | 26-10-14 |
Eran Schenker
CTO | Chief Tech/Sci/R&D Officer | 61 | 04-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ophir Shahaf
BRD | Director/Board Member | 57 | 14-03-19 |
Erez Alroy
BRD | Director/Board Member | 63 | 11-08-14 |
Rani Lifshitz
CHM | Chairman | 57 | 11-05-14 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+9,30% | 45,97 mld. | |
+52,73% | 43,93 mld. | |
+7,15% | 42,34 mld. | |
-8,78% | 28,27 mld. | |
+18,68% | 27,18 mld. | |
-21,92% | 19,44 mld. | |
+14,62% | 13,83 mld. | |
+31,85% | 12,4 mld. | |
+4,47% | 11,45 mld. |